Related Experiment Video

Updated: May 28, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

[Clinical report on 68 cases of refractory mycoplasma pneumoniae pneumonia (RMPP)]

Lei Wang1, Jian-Hua Duan

  • 1Beijing Children's Attached Hospital of Capital Medical University, 100045, China.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology
|October 8, 2011
PubMed
Abstract

Insights

Early diagnosis and combined treatments are key for Refractory Mycoplasma Pneumoniae Pneumonia (RMPP). This review summarizes essential diagnostic and therapeutic strategies for RMPP management.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Clinical microbiology

Context:

  • Refractory Mycoplasma Pneumoniae Pneumonia (RMPP) presents a diagnostic and therapeutic challenge.
  • Understanding early clinical and radiological signs is vital for timely intervention.
  • This study reviews 68 cases to elucidate optimal management pathways.

Purpose:

  • To summarize early diagnostic methods for RMPP.
  • To outline effective treatment strategies for RMPP.
  • To highlight the role of bronchofibroscopy in RMPP management.

Summary:

  • High fever and evolving lung opacities on imaging are characteristic of RMPP.
  • Treatment typically requires multiple rounds of macrolides and methylprednisolone.
  • Antibiotics and immunoglobulin may be used adjunctively based on clinical presentation and response.

Impact:

  • Emphasizes the critical role of early diagnosis in improving RMPP outcomes.
  • Advocates for a multimodal treatment approach for successful RMPP resolution.
  • Provides a clinical reference for managing complex pediatric pneumonia cases.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.